Which imaging study uses a contrast agent to improve visibility of vessels, organs, and abnormalities?

• A. Ultrasound
• B. Contrast-enhanced CT
• C. MRI without contrast
• D. X-ray without contrast

Answer: (B)

Using a contrast agent to improve visibility on imaging hinges on how the agent changes how tissues appear on the scan, making vessels, organs, and potential abnormalities stand out more clearly. In a contrast-enhanced CT study, an iodinated contrast material is injected and increases X-ray attenuation in blood vessels and many organs. This makes those structures appear brighter on the images, which helps map blood flow, delineate organ outlines, and highlight abnormalities such as tumors, inflammation, or hemorrhage. The timing of imaging after contrast injection (arterial, venous, or delayed phases) can enhance different tissues and lesions, aiding diagnosis.

Other modalities may use contrast for specific purposes, but they don’t fit the description as universally as contrast-enhanced CT. Ultrasound can be enhanced with contrast in some cases, but standard ultrasound relies on sound waves rather than a radiopaque agent; MRI without contrast won’t provide the enhanced detail described; X-ray without contrast lacks the vascular and soft-tissue enhancement that contrast agents provide.